(Q37063766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22549563%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Safety of prednisone for ocular myasthenia gravis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22549563%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22549563%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Mark J Kupersmith

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22549563%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22549563%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro Ophthalmology

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22549563%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22549563%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22549563%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

212-215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22549563%20AND%20SRC:MED&resulttype=core&format=json

Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review

30 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

Steroids and immunosuppressant drugs in myasthenia gravis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

Treatment of ocular myasthenia: steroids only when compelled

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

Ocular myasthenia gravis: response to long-term immunosuppressive treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

Oral corticosteroids in the treatment of ocular myasthenia gravis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

Long-term effects of combined immunosuppressive treatment on myasthenic crisis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

Does early treatment of ocular myasthenia gravis with prednisone reduce progression to generalized disease?

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

Development of generalized disease at 2 years in patients with ocular myasthenia gravis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731151

Polymyalgia rheumatica and giant cell arteritis; diagnosis and side effects of low-dose long-term glucocorticoid therapy

4 September 2018

1 reference

12 December 2020

Does early immunotherapy reduce the conversion of ocular myasthenia gravis to generalized myasthenia gravis?

1 reference

12 December 2020

Oral corticosteroids in the treatment of ocular myasthenia gravis

1 reference

12 December 2020

Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients

1 reference

12 December 2020

10.1097/WNO.0B013E3182536558

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22549563%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22549563%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

PubMed publication ID

22549563

1 reference